Related content

Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery

By  

Current Drug Metabolism, Vol. 18, Iss. 12, 2018-02 ,pp. : 1095-1105

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients

By Miura Masatomo   Satoh Shigeru   Kagaya Hideaki   Saito Mitsuru   Numakura Kazuyuki   Tsuchiya Norihiko   Habuchi Tomonori  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 977-984

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

By Eap Chin   Buclin Thierry   Hustert Elisabeth   Bleiber Gabriela   Golay Kerry   Aubert Anne-Catherine   Baumann Pierre   Telenti Amalio   Kerb Reinhold  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Statin regulation of CYP3A4 and CYP3A5 expression

By Willrich Maria Alice Vieira   Hirata Mario Hiroyuki   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 1017-1024

Future Medicine

Access to resources Recommend Favorite

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43

By Krusekopf S.   Roots I.   Kleeberg U.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite